AI assistant
10x Genomics, Inc. — Director's Dealing 2021
May 27, 2021
31830_dirs_2021-05-26_2541926f-1c7b-47ca-80bc-c10b1201dee6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: 10x Genomics, Inc. (TXG)
CIK: 0001770787
Period of Report: 2021-05-24
Reporting Person: Kosaraju Sridhar (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-05-24 | Class A Common Stock | S | 400 | $160.0513 | Disposed | 14600 | Indirect |
| 2021-05-24 | Class A Common Stock | S | 700 | $161.1507 | Disposed | 13900 | Indirect |
| 2021-05-24 | Class A Common Stock | S | 300 | $162.0533 | Disposed | 13600 | Indirect |
| 2021-05-24 | Class A Common Stock | S | 100 | $163.04 | Disposed | 13500 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Class A Common Stock | 2833 | Direct |
Footnotes
F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Kosaraju Family Trust.
F2: This transaction was executed in multiple trades at prices ranging from $159.64 to $160.605. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F3: These shares are held by the Kosaraju Family Trust dated June 21, 2014, of which the Reporting Person is trustee (the "Kosaraju Family Trust").
F4: This transaction was executed in multiple trades at prices ranging from $160.66 to $161.635. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F5: This transaction was executed in multiple trades at prices ranging from $161.91 to $162.14. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.